These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29878063)

  • 1. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on SAMS: Statin-associated muscle symptoms.
    Stock JK
    Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
    Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
    Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
    Iatan I; Mancini GBJ; Yeoh E; Hegele RA
    Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a More Personalized Treatment of Dyslipidemias to Prevent Cardiovascular Disease.
    Hoffmann MM
    Curr Cardiol Rep; 2018 May; 20(7):56. PubMed ID: 29802474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic predisposition to statin myopathy.
    Vladutiu GD
    Curr Opin Rheumatol; 2008 Nov; 20(6):648-55. PubMed ID: 18946323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle and statins: from toxicity to the nocebo effect.
    Pedro-Botet J; Climent E; Benaiges D
    Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
    Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
    Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin myotoxicity: a review of genetic susceptibility factors.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2014 Jan; 24(1):4-15. PubMed ID: 24176465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to clinical and genetic characterization of statin-induced myopathy.
    Feng Q
    Methods Mol Biol; 2014; 1175():67-90. PubMed ID: 25150867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Options for Statin-Associated Muscle Symptoms.
    Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
    Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of statin-induced myopathy and perspectives for the future.
    Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
    Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
    Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
    Taylor BA; Thompson PD
    Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COQ2 polymorphisms are not associated with increased risk of statin-induced myalgia/myopathy in the Czech population.
    Hubacek JA; Adamkova V; Zlatohlavek L; Steiner-Mrazova L; Vrablik M
    Drug Metab Pers Ther; 2017 Dec; 32(4):177-182. PubMed ID: 29257754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin intolerance.
    Laufs U; Scharnagl H; März W
    Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
    [No Abstract]   [Full Text] [Related]  

  • 19. A comprehensive review and meta-analysis of risk factors for statin-induced myopathy.
    Nguyen KA; Li L; Lu D; Yazdanparast A; Wang L; Kreutz RP; Whipple EC; Schleyer TK
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1099-1109. PubMed ID: 29785580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.